Osaic Holdings Inc. Has $1.95 Million Stock Holdings in VanEck Pharmaceutical ETF $PPH

Osaic Holdings Inc. grew its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 82.4% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 22,125 shares of the company’s stock after purchasing an additional 9,992 shares during the period. Osaic Holdings Inc.’s holdings in VanEck Pharmaceutical ETF were worth $1,946,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Clal Insurance Enterprises Holdings Ltd acquired a new position in VanEck Pharmaceutical ETF during the 2nd quarter valued at about $28,587,000. JPMorgan Chase & Co. lifted its stake in VanEck Pharmaceutical ETF by 2,852.2% in the second quarter. JPMorgan Chase & Co. now owns 255,837 shares of the company’s stock valued at $22,503,000 after buying an additional 247,171 shares during the period. Verity & Verity LLC acquired a new position in VanEck Pharmaceutical ETF in the second quarter valued at about $11,551,000. Tower Research Capital LLC TRC boosted its holdings in VanEck Pharmaceutical ETF by 346,140.0% during the second quarter. Tower Research Capital LLC TRC now owns 34,624 shares of the company’s stock worth $3,046,000 after buying an additional 34,614 shares during the last quarter. Finally, Royal Bank of Canada grew its position in shares of VanEck Pharmaceutical ETF by 53.3% during the 1st quarter. Royal Bank of Canada now owns 67,596 shares of the company’s stock worth $6,160,000 after buying an additional 23,491 shares during the period.

VanEck Pharmaceutical ETF Price Performance

Shares of PPH stock opened at $104.43 on Monday. The stock has a market cap of $1.29 billion, a PE ratio of 20.21 and a beta of 0.54. The stock has a 50-day moving average of $98.30 and a 200-day moving average of $91.94. VanEck Pharmaceutical ETF has a one year low of $77.67 and a one year high of $104.46.

VanEck Pharmaceutical ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, October 6th. Shareholders of record on Wednesday, October 1st were issued a $0.3931 dividend. The ex-dividend date was Wednesday, October 1st. This represents a $1.57 annualized dividend and a yield of 1.5%.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.